Titus Naa Yeng is a PhD candidate in Comparative and Experimental Medicine at the University of Tennessee, specializing in experimental oncology and regenerative medicine. His research examines how obesity reprograms adipose stromal cells (ASCs) and reshapes the colorectal cancer (CRC) microenvironment. He investigates ASC-driven extracellular matrix remodeling, inflammatory signaling, and metabolic/redox adaptations, and how weight loss remodels these tumor-modulating programs. Using integrative 3D co-culture and organotypic models, transcriptomic profiling, and in vivo validation, his work aims to define mechanisms linking obesity to epithelial–mesenchymal transition, therapy resistance, and early-onset CRC risk. Ultimately, he seeks to identify targetable stromal and metabolic vulnerabilities to improve CRC prevention and treatment outcomes. He has a background in biomedical laboratory science and prior research experience in oxidative stress in metabolic disease.
Titus Naa Yeng is a PhD candidate in Comparative and Experimental Medicine at the University of Tennessee, specializing in experimental oncology and regenerative medicine. His research examines how obesity reprograms adipose stromal cells (ASCs) and reshapes the colorectal cancer (CRC) microenvironment. He investigates ASC-driven extracellular matrix remodeling, inflammatory signaling, and metabolic/redox adaptations, and how weight loss remodels these tumor-modulating programs. Using integrative 3D co-culture and organotypic models, transcriptomic profiling, and in vivo validation, his work aims to define mechanisms linking obesity to epithelial–mesenchymal transition, therapy resistance, and early-onset CRC risk. Ultimately, he seeks to identify targetable stromal and metabolic vulnerabilities to improve CRC prevention and treatment outcomes. He has a background in biomedical laboratory science and prior research experience in oxidative stress in metabolic disease.